Bisphosphonates: GGPS1 Mutation and Atypical Femoral Fractures
May 05, 2017 – This report nicely illustrates how, by both clever study design and selection of according phenotypic patients, genetic predispositions for even very rare serious adverse drug reactions (sARD) can be elucidated, which eventually may lead to theragenomics-based therapy …
Bisphosphonates: GGPS1 Mutation and Atypical Femoral Fractures Read more »